机译:艾塞那肽单药治疗肥胖的新诊断2型糖尿病患者的疗效和耐受性:一项随机,26周,以二甲双胍为对照的平行组研究
Department of Endocrinology, Peking University First Hospital,Beijing 100034, China;
Huguosi Hospital of Traditional Chinese Medicine, Beijing University of Chinese Medicine and Pharmacology, Beijing 100035, China;
Department of Endocrinology, Peking University First Hospital,Beijing 100034, China;
Department of Endocrinology, Peking University First Hospital,Beijing 100034, China;
Department of Endocrinology, Peking University First Hospital,Beijing 100034, China;